The researchers examined data on opioid tablets and patches
dispensed or prescribed by 134 veterinarians at an academic
small-animal hospital in Philadelphia from 2007 to 2017. Over the
decade, the amount of opioids used for creatures like rabbits, birds
and reptiles surged 41 percent even though visits to the hospital
increased by only 13 percent.
"We have no way of knowing if any of these prescriptions were
obtained by pet owners for themselves, and most were likely not,"
said senior study author Dr. Jeanmarie Perrone, a toxicologist with
the emergency medicine department at the Perelman School of Medicine
at the University of Pennsylvania in Philadelphia.
"However, the risk to humans is that leftover opioid prescriptions
to animals end up in the same medicine cabinets as leftover opioids
for people, leading to opportunities for misuse by teenagers or
unintentional exposures in children that can be lethal," Perrone
said by email.
The study included 366,468 pet visits to the animal hospital. During
these visits, veterinarians prescribed a total of 105.2 million
tablets of tramadol, more than 97,000 tablets of hydrocodone, almost
39,000 tablets of codeine and 3,153 fentanyl patches.
Dogs got the most drugs, accounting for 73 percent of these
prescriptions, followed by cats at 22.5 percent and exotic animals
at 4.5 percent.
A major factor contributing to the growing opioid crisis in the U.S.
is the increasing availability of these drugs, which addicts often
get from friends or relatives when they aren't able to obtain a
prescription, researchers note in JAMA Network Open.
Although medical and dental health providers are the biggest source
of these opioids, the current study suggests that veterinary
prescriptions may also be part of the problem, they write.
Veterinarians and animal hospitals can be registered with the U.S.
Drug Enforcement Administration, and in many states vets can
prescribe, stock and dispense opioids without the same reporting
requirements that are in place at many retail outlets. Only 20
states require veterinarians to report opioid prescribing as medical
doctors do to a registry designed to limit misuse, the study authors
note.
[to top of second column] |
Pennsylvania is one of many states without reporting requirements,
and results from the study may reflect what happens in other states
that lack registries to help curb abuse, Perrone said.
It's not clear if the increase in prescriptions in Pennsylvania
might be due to an increased push to better manage pain for animals
and pets, said Dr. Lee Newman, a researcher at the Colorado School
of Public Health, University of Colorado, CU Anschutz Medical Campus
in Aurora. Or, if it is due to the growing number of people with
substance abuse problems trying to get medications from
veterinarians - or both.
"It's speculation on my part, but it could be that when a human
patient stops getting opioid prescriptions from their doctor that
they next turn to the veterinarian to try to get drugs," Newman, who
wasn't involved in the study, said by email.
While the study suggests that opioid prescribing from veterinarians
represents only a small fraction of the overall opioid prescribing
in the country, it also suggests that veterinary practices may be an
overlooked part of the problem, said Kirk Evoy of the University of
Texas at Austin College of Pharmacy and University Health System in
San Antonio.
"This study brings to light that this is yet another potential
source of access to opioids that many clinicians and policymakers
may not be thinking about in their efforts to curtail the country's
opioid abuse epidemic," Evoy, who wasn't involved in the study, said
by email.
"Furthermore, while human opioid prescribing has begun to level off
in recent years in response to the opioid epidemic, this data seems
to indicate that, at least in the specific hospital being studied,
prescribing of opioids for animals has continued to climb," Evoy
said.
SOURCE: https://bit.ly/2UQ1EoQ JAMA Network Open, online January 11,
2019.
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |